发明名称 |
Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine |
摘要 |
The present disclosure generally relates to a crystalline form of 6-[(4S)-2-methyl-4-(naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine. The present disclosure also generally relates to pharmaceutical compositions comprising the crystalline form, as well of methods of using a crystalline form in the treatment of depression and other conditions and methods for obtaining such crystalline form. |
申请公布号 |
US9498476(B2) |
申请公布日期 |
2016.11.22 |
申请号 |
US201514841024 |
申请日期 |
2015.08.31 |
申请人 |
Albany Molecular Research, Inc. |
发明人 |
Qiu Jun;Gao Qi;Liu Shuang;Hu Min;Yang Yuh-Lin Allen;Isherwood Matthew;Amin Rasidul |
分类号 |
A61K31/435;A61K31/495;A61K31/501;C07D401/04 |
主分类号 |
A61K31/435 |
代理机构 |
LeClairRyan, a Professional Corporation |
代理人 |
LeClairRyan, a Professional Corporation |
主权项 |
1. A method of treating depression in a mammal in need thereof comprising administering to the mammal a therapeutically-effective amount of Form N-1 of |
地址 |
Albany NY US |